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Abstract
The role of microRNAs (miRNAs) as a post-transcriptional gene regulator has been elucidated in a broad range of organisms
including domestic animals. Characterization of miRNAs in normal tissues is an important step to investigate the functions
of miRNAs in various physiological and pathological conditions. Using Illumina Next Generation Sequencing (NGS)
technology, we identified a total of 292 known and 329 novel miRNAs in normal horse tissues including skeletal muscle,
colon and liver. Distinct sets of miRNAs were differentially expressed in a tissue-specific manner. The miRNA genes were
distributed across all the chromosomes except chromosomes 29 and 31 in the horse reference genome. In some
chromosomes, multiple miRNAs were clustered and considered to be polycistronic transcript. A base composition analysis
showed that equine miRNAs had a higher frequency of A+U than G+C. Furthermore, U tended to be more frequent at the 59
end of miRNA sequences. This is the first experimental study that identifies and characterizes the global miRNA expression
profile in normal horse tissues. The present study enriches the horse miRNA database and provides useful information for
further research dissecting biological functions of miRNAs in horse.
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Introduction
MicroRNAs (miRNAs) play a crucial role in various physiolog-
ical and pathological conditions in a broad range of organisms
from viruses to animals [1–2]. The short non-coding RNAs
regulate the expression of thousands of genes by partial or
complementary binding to target mRNAs, resulting in transla-
tional inhibition and/or degradation of the target mRNAs [3–5].
The mature miRNAs are generated from serial stepwise processing
[6]. The enzyme Drosha cleaves the single stranded primary
miRNA transcripts(pri-miRNAs) to produce a precursor stem-loop
secondary structure(pre-miRNAs) [7]. In turn, the pre-miRNAs
are cleaved by the enzyme Dicer to produce mature miRNA
duplexes [8]. Only one of the two strands acts as a regulatory RNA
associated with RNA-induced silencing complex (RISC) [9].
The importance of miRNAs has been recently recognized in
veterinary medicine. There is increasing interest in canine
miRNAs because of their clinical relevance for human breast
cancers [10–11]. Down-regulation of miR-130 and miR-30 in
canine heart plays an important role in the pathogenesis of chronic
atrial fibrillation [12]. Distinct sets of miRNAs including miR-122,
miR-193b, and miR-483 were reported to be involved in the
development of type-2 diabetes mellitus in cats [13]. A large
number of miRNAs have been identified in normal tissues of swine
and bovine species [14–17]. However, information about equine
miRNAs and their role in clinical conditions is scarce. Recently, in
silico analytical methodology was applied to identify and charac-
terize mature 354 equine miRNAs [18]. A study revealed 82 new
miRNAs in equine sperms, suggesting the role of miRNAs in the
regulation of sperm function, fertility and reproduction [19].
Barrey et al. [20] described the expression profile of muscular
miRNAs in healthy and myopathic horses using a direct cloning
technology.
Forward genetics, bioinformatics and direct cloning have been
utilized to study miRNAs [21]. Recently, next generation
sequencing (NGS) technology has emerged as a major tool to
scrutinize small RNAs including miRNAs [22]. An important
feature of the NGS is parallel sequencing of clonally amplified or
single DNA molecules that are spatially separated in a flow cell
[23]. Due to its ability to generate millions of reads with
determined lengths, NGS greatly improves the capacity to identify
a large number of novel miRNAs on a genomic scale [24].
Domestic horse, Equus caballus, has been a crucial part of human
civilization [25–26]. It is economically important throughout the
world and has been used for transportation and entertainment.
Moreover, horse is a medically valuable animal model because the
species shares over 90 hereditary conditions with human disorders
[27–28] as well as many medical conditions such as allergies and
osteoarthritis [29–30]. Furthermore, horse can be a valuable
model organism for studying biomechanics and exercise physiol-
ogy [31]. The present study was performed to characterize
miRNAs in normal horse tissues by using Illumina high-
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throughput NGS technology. Our study identifies a list of known
miRNAs as well as candidates for novel miRNAs in horse tissues.
Additionally, characteristics of horse microRNAs including
expression patterns in major tissues, sequence composition and
chromosomal distribution were determined. Our study provides
background data and information to facilitate research on the role
of miRNAs in the pathogenesis of various conditions in horses.
Results
Library construction of small RNAs from horses
We performed high-throughput short read sequencing of small
RNAs from skeletal muscle, liver, and colon tissues from eight
Thoroughbred horses. A number of reads, with counts ranging
from 11973300 to 21838589, were obtained from the cDNA
libraries of small RNAs, of which approximately 100% were of
high quality. After eliminating 39 adapter null, 59 adapter
contaminants, insert null, smaller than 18 nucleotides (nts) and
poly A sequences, more than 94% of clean reads in all tissue
samples were subjected to further analyses using bioinformatic
tools (Table S1). The resultant small RNAs ranged from 18 to
30 nts in length, with the majority having a length of 22 nt.
In general, small RNA libraries generated by NGS is complex in
composition because they harbor a large number of degradation
fragments derived from coding and noncoding transcripts [32]. To
annotate the small RNAs generated by NGS, we performed a
BLAST that search of the small RNAs against the equine genome
database. Unique small RNAs from muscle, colon, and liver tissues
were annotated against the NCBI Genbank and Rfam databases.
The annotation results showed that non-coding RNA including
exons, introns, repeats, rRNA, scRNA, snRNA, snoRNA,
Figure 1. Length distribution and abundance of all miRNAs in horse muscle, colon, and liver tissues. Approximately 83% of all
sequences in horse tissues are concentrated in the 20–24 nt range. The most frequent length is 23 nt in all tissues.
doi:10.1371/journal.pone.0093662.g001
Figure 2. Venn diagram representing the distribution of known
and novel miRNAs in horse muscle, colon, and liver tissues.
Counts in the Venn diagram are the number of miRNAs identified in
each tissue. A total 292 known (A) and 329 novel miRNAs (B) are
identified in horse tissues including muscle, colon, and liver.
doi:10.1371/journal.pone.0093662.g002
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srpRNA, and tRNA accounted for a large percentage of the
unique read counts. It also revealed that miRNAs constituted a
small portion of the unique read counts but a significant portion of
overall read counts (Table S2). More than 70% of unique
sequences in all the tissues could not be classified. The sequences
of unannotated small RNAs that could be mapped to the equine
genome were subject to further analyses to identify novel miRNA
candidates.
Expression profile of miRNAs in major organs
To identify previously reported miRNAs in horse tissues, the
small RNAs were submitted for a BLAST search against known
equine miRNAs and their precursors in the latest miRBase release
version 15.0 [32]. As a result, a total of 201 families including 292
known miRNAs were detected across horse samples (Table S3).
The length distribution of known miRNAs was similar in all
samples mainly 22–24 nts (Figure 1). The expression profile of
known miRNAs in horse tissues was analyzed (Figure 2A). Subsets
of tissue-specific miRNAs were identified: 36 miRNAs in muscle
samples, 99 miRNAs in colon samples, and 31 miRNAs in liver
samples (Table S4).
Identification of novel equine miRNAs
To identify candidates for novel equine miRNAs, a prediction
software Mireap (http://sourceforge.net/projects/mireap/) was
used to determine secondary structures, the Dicer cleavage sites
and the minimum free energy of the unannotated small RNA tags
[33]. Based on the analytical criteria, a total of 329 unannotated
miRNA sequences were determined as candidates for novel
miRNAs in horse (Table S5). The putative novel miRNAs
exhibited a concentrated length distribution between 20 nt and
24 nt, with a peak at 21,22 nt (Figure 3). Expression profile of the
novel miRNAs in horse tissues was investigated (Figure 2B).
Similar to the known miRNAs, subsets of novel miRNAs were
expressed in a tissue-specific manner: 31 novel miRNAs in muscle
samples, 123 novel miRNAs in colon samples, 45 novel miRNAs
in liver samples (Table S6). Read counts of most novel miRNAs
were less than 100 (Data not shown).
Mapping to genome and miRNA transcriptional units
A total of 292 known miRNAs were mapped across the 32 horse
chromosomes with the exception of chromosomes 29 and 31
(Figure 4). We attempted to determine whether equine miRNAs
show expression patterns representing single transcriptional units.
In our analysis, if two miRNAs were within 3 kb of each other,
they were considered to be in the same cluster [34]. We found that
up to 160 miRNAs were closely co-localized in clusters with the
3 kb threshold. The equine genome contains 51 miRNA clusters
with 160 miRNAs accounting for approximately 55% of the
known miRNAs (Figure 5). The clusters were variably located on
individual chromosome. For example, 40 miRNA genes in 4
clusters were mapped to chromosome 24, while only 2 miRNA
genes were mapped to chromosomes 6, 12, 14, 16, 18, and 20
(Table 1).
Nucleotide bias of equine miRNAs
The first nucleotide at the 59 end of organ-specific miRNAs of
any length was predominantly U with a frequency of 40%, 35%,
and 43% in muscle, colon, and liver tissues, respectively (Figure 6).
Likewise, G and A were the only preferred nucleotide at the 59 end
of 18 and 19 nt long miRNAs in colon, although very short
miRNAs that were 18 to 19 nt long were rare in horse. The base
composition at each position of all mature miRNAs revealed a
clear tendency for U being the most frequently observed
nucleotide at specific sites (1, 9, 21, 23–26, and 28). However, C
was the least used nucleotide at specific sites (3, 7, 12, 13, 15, 16,
18, 19, 21, 24, and 25) in all tissue miRNA sequences. The
distribution of A+U, accounting for an average of 72%, was
generally preferred to C+G in all tissue samples (Figure 7). In
contrast, from third to sixth nucleotide positions, C+G was more
abundant than A+U in all tissue-specific miRNAs. Furthermore,
from the second to eighth nucleotide positions, which belong to the
seed region of miRNAs, colon miRNAs showed prominent C+G
compared to A+U (Data not shown) [35].
Discussion
Using Illumina short read sequencing technology, a total of 292
known and 329 novel miRNAs were identified in equine tissues
including muscle, liver, and colon. Furthermore, it was found that
subsets of miRNAs were differentially expressed in horse tissues,
suggesting tissue-specific behavior of equine miRNAs. The
identification and characterization of equine miRNAs was carried
out using NGS technology to obtain millions of small RNA
sequences and to construct small RNA differential expression
profile in target organs [23]. Although NGS has the advantage of
cloning small RNAs exclusively, it has several disadvantages
compared to computational approaches [41]. The limitations
include the difficulty of finding miRNAs that are expressed at a
low level and a cloning inability due to physical properties such as
sequence composition and/or post-transcriptional modifications
[42]. Further studies are warranted to elucidate a comprehensive
list of equine miRNAs that are biologically important.
Although horses are one of the most important domestic
animals, research on equine miRNAs has been limited [36].
Figure 3. Length distribution of novel miRNAs in horse tissues.
miRNA sequences of all lengths are distributed in the 20–24 nt range.
The most frequent length is 22 nt (34.65%) in horse miRNAs.
doi:10.1371/journal.pone.0093662.g003
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Attempts have recently been made to investigate the role of equine
miRNAs in various conditions. A study using direct sequencing
verified two miRNAs, miR-433 and -127, in horse, thus proving
the conservation of the miRNAs throughout mammalian species
[37]. Zhou et al.[18] discovered a total of 354 mature miRNAs
through an integrated computational analysis of an equine
genome, providing a baseline for horse miRNA research.
Additionally, they presented valuable references for all major
sequence characteristics of horse miRNAs, such as the contents of
each nucleotide, A+U, C+G, and base composition at each
position of pre-miRNA and mature miRNA sequences. Recently,
expression profiles of 82 miRNAs were characterized in equine
sperms, indicating their role in the regulation of sperm function,
fertility, and reproduction [19]. A study revealed that 10 miRNAs
were significantly expressed in equine muscles, some of which were
also expressed in blood samples [20]. The present study provides
the first experimental data on expression profile of global equine
miRNAs using NGS technology, some of which were previously
reported in an in silico study [18].
In horse, the characterization of miRNAs in major organs
including liver, skeletal muscle, and large intestine has significant
clinical relevance to important equine diseases. Horses are more
prone to develop colic, a fatal disease complex resulting from
numerous factors including strangulation, obstruction and volvulus
[38]. Approximately 34% of horses undergoing an exploratory
laparotomy had displacement or volvulus of the large colon due to
its free mobility in the abdominal cavity [38–39]. Unfortunately,
despite the magnitude of the problem of equine colic, relatively
little has been known about exact causes. Because of their nature
and human usage, horses are affected by various types of muscle
diseases including exercise-associated myopathy, post-exhaustion
syndrome, and nutritional myopathy [40]. Horses frequently
develop liver disease because of their grazing habits, causing
significant economic losses [41]. Given that the expression profile
of miRNA is specific for organs and/or tissues [3], it is clinically
Figure 4. Chromosomal locations of 292 known miRNA genes in horse. Black vertical lines represent the miRNA gene, the depth of color
represents the number of miRNA genes in this region. The relative locations of individual miRNAs across the 32 horse chromosomes are shown with
the exception of chromosomes 29 and 31.
doi:10.1371/journal.pone.0093662.g004
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important to discover subsets of organ-specific miRNAs. Our
study revealed that both known and novel miRNAs in colon have
a larger proportion of total miRNAs than other tissues. In contrast
to other mammals, the equine large intestine has relatively
complicated anatomical structures and physiological functions to
facilitate a steady flow of nutrient [42]. Our data may indicate that
the colon-specific miRNAs have more sophisticated roles in the
colon’s regulatory system [17].
Barrey et al. [20] demonstrated that muscle-specific miRNAs
were also detected in blood samples of horses with heritable
muscular pathology. The study suggested the potential value of the
miRNAs for the development of novel and minimally invasive
methodology for diagnosing muscular pathology in horses [20].
Similarly, further studies are warranted to investigate expression
profile of tissue-specific miRNAs in the blood and may provide
valuable biomarker to identify organ damage and various disease
conditions.
Characterization of 59-end sequences of the miRNA is
important because seed sequence of a miRNA is critical in
miRNA-target mRNA binding [4–43]. Analysis of nucleotide
sequences in eukaryotic miRNAs showed a clear bias for U or A at
the 59 position [44]. Our study revealed that U was the most
frequent nucleotide at the 59-end of tissue-specific miRNAs,
followed by A. This finding is consistent with results from the
published studies on miRNAs of other organisms [18–32–33–45].
In plant, U at the end of 59 was proposed as being critical for the
biogenesis of miRNAs through the recognition of targeted miRNA
precursor by RISC [46]. The C+G contents in the 6th position of
the seed region were known to induce or enhance the function of a
miRNA [45]. In our study, all tissue miRNAs had high
percentages of C+G from the third to sixth positions in the
sequence. The miRNAs in colon had more distinct sequence bias
showing high percentage of C+G in all of the seed nucleotides such
a bias may be responsible for distinct functions in colon compared
to different organs [45]. The base bias in seed sequence may
provide a valuable reference for further study on the identification
of regulatory cellular function of miRNAs.
In our study, the equine miRNAs were located on diverse
chromosomes. An intriguing feature was that the distribution of
miRNAs along the chromosomes was uneven; some chromosomes
were relatively miRNA-rich while others were miRNA-poor.
Based on chromosomal mapping, more than half of the known
miRNAs that exists within 3 kb threshold of each other were
considered as a polycistronic transcript. It is interesting to note that
our study revealed a number of putative miRNA clusters in horse
genome. Consistent with a published study on horse miRNAs [18],
a miR-17-92 cluster was also detected on chromosome 17 in our
study. This cluster is reportedly harboring miR-17, miR-18a, miR-
19a, miR-19b, miR-20a, and miR-92a, and is a well-preserved
cluster in human and all vertebrates [11–18]. In mammals, the
miR-17-92 cluster is divided into two cluster paralogs: miR-106b-
25 cluster and the miR-106a-363 cluster [47]. In our study, the
former cluster was located on chromosome 13 and the latter
cluster on chromosome X. Further studies addressing the precise
role of polycistronic transcripts in horse may enhance our
understanding about the mechanisms of miRNA generation.
The present study revealed that approximately 53% of the
known miRNAs were observed as part of a polycistronic unit. The
finding suggests that the clustering property of miRNAs is
preserved in horse, although there is partial discrepancy in
chromosomal location compared with human data [47]. The
proportion of miRNAs in polycistronic units is similar to that of
zebrafish miRNAs (50%) [48]. It is noteworthy that approximately
72% of clustered equine miRNAs in our study correspond to those
detected by the computational analysis of horse [18]. However, 45
of the 160 miRNAs that are considered as a polycistron could not
be identified at orthologous positions in the in silico study [18]. We
speculated that difference in analysis methodologies is responsible
for this discrepancy in miRNA clustering. In our study the miRNA
clustering was made based on sequence data from NGS
Figure 5. Chromosomal locations of polycistronic miRNAs in horse. Individual black horizontal lines represent polycistronic miRNA
transcripts, the stars refer to multiple miRNA genes in this region. The relative locations of individual miRNAs that are considered as a polycistron are
within 3 kb.
doi:10.1371/journal.pone.0093662.g005
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Table 1. Polycistronic miRNAs in horse genome.
Chr Polycistronic miRNAs Positions in chr
2 miR-200b, miR-200a, miR-429 48455071–48453091
2 miR-30e, miR-30c 17435650–17432816
3 miR-95, miR-218 103550531–103550551
3 miR-328, miR-138 9201088–9201162
4 miR-29b, miR-29a 85327107–85326792
4 miR-183, miR-96 84472003–84471849
5 miR-153-2, miR-101 95527968–95527988
5 miR-205, miR-16, miR-15b 15685339–15685252
6 miR-141, miR-200c 34423490–34423144
7 miR-492-2, miR-708 54764367–54764389
7 miR-492-2, miR-24, miR-27a, miR-23a 44930206–44929889
7 miR-100, miR-125b 29500017–29500052
7 miR-34c, miR-34b 20101717–20101221
7 miR-34b, miR-7-2 2932730–2932799
8 miR-133a, miR-1 39912260–39912288
8 miR-130b, miR-301b 3383110–3382875
10 miR-99b, let-7e, miR-125a 21370890–21371640
11 miR-497, miR-195 50049193–50048962
11 miR-212, miR-132 45640251–45639901
11 miR-144, miR-451 42750581–42750479
12 miR-194, miR-192 25044429–25044298
13 miR-106b, miR-93, miR-25 8034691–8034329
13 miR-193b, miR-365-2 30682640–30682716
14 miR-143, miR-145 28434698–28433339
16 miR-191, let-7g 35442186–35442267
17 miR-92a, miR-19b, miR-20a, miR-19a, miR-18a, miR-17 61793120–61792474
17 miR-16-2, miR-15a 21138923–21138839
18 miR-10b, miR-128-2 19492393–19492419
20 miR-582, miR-30c-2 62697786–62697808
23 miR-342, let-7f, let-7d 54150817–54148904
23 miR-204b-2, miR-7-3 6798843–6798880
23 miR-23b, miR-27b, miR-24-2 2317924–2317244
24 miR-656, miR-541, miR-496, miR-412, miR-410, miR-409, miR-377 42937011–42930226
miR-369, miR-154
24 miR-485, miR-134, miR-382, miR-487a, miR-655, miR-544-2, miR-889 42925986-42911169
miR-539, miR-487b, miR-381, miR-1185, miR-376a, miR-376b, miR-376c
24 miR-495, miR-543, miR-1193, miR-494, miR-329, miR-758, miR-323 42906084–42894709
miR-1197, miR-380, miR-299, miR-411, miR-379
24 miR-136, miR-432, miR-127, miR-433, miR-431 42748685–42745108
25 miR-181b, miR-181a 28673901–28672731
25 miR-126, miR-219-2 31667420–31667458
26 miR-99a-2, miR-125b-2, let-7c 15508980–15509792
28 let-7a, let-7a-2 42016391–42016461
28 miR-33a, miR-135a-2 22270420–22270497
30 miR-653, miR-181a-2 26398982–26399027
30 miR-664, miR-194-2, miR-215 10337974–10337730
X miR-424, miR-503 106954949–106954687
X miR-542, miR-451a, miR-450a, miR-450b 106949741–106948733
X miR-106a, miR-18b, miR-20b, miR-19b-2, miR-92a-2, miR-363 106692701–106691957
Equine MicroRNA by NGS
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technology, whereas the in silico study utilized a limited number of
miRNAs identified by BLAST search. Zhou et al. [18] reported
polycistronic miRNAs such as miR-302a, -302b, -302c, -302d, and
-367 on chromosome 2 and miR-1912 and -1264 on chromosome
X, these were not found in our result. In contrast, newly found
polycistronic miRNAs in our study were not reported by Zhou et.
al [16]. A number of questions for the clustering property for
equine miRNAs remain to be clarified in further studies.
Conclusions
In the present study, we identified 292 known and 329 novel
miRNAs in normal equine tissues by using NGS technology. This
study significantly enriches the horse miRNA database and
presents a valuable reference for equine miRNAs. In addition,
the global miRNA expression profile in equine tissues revealed
that distinct sets of miRNAs were expressed in a tissue-specific
pattern. Clustering in chromosomes and sequence characteristics
of miRNA may be useful for dissecting their biological functions in
horse. Taken together, the present study suggests that equine
miRNAs may play an important role in development and function
of specific tissues, and therefore, they can be developed as a
valuable molecular marker for various pathophysiological condi-
tions.
Materials and Methods
Ethics statement
Animals were sampled with the appropriate consent from horse
owners. These horses sacrificed were humanely euthanized
following Institutional Animal Care Guidelines for Experimental
Animal Use and approved by the Seoul National University
Animal Care Committee.
Tissue collection and high-throughput sequencing of
small RNAs
Before the sacrifice, the animals were determined to be healthy
based on the results from physical exams, clinical observations and
clinicopathologic tests. Major organs including skeletal muscle,
liver, and colon were collected immediately after the sacrifice.
Collected tissue samples were snap-frozen in liquid nitrogen and
stored at 280uC until use. Total RNAs were isolated by a phenol-
chloroform method with Trizol reagent (Invitrogen, Carlsbad, CA,
USA) according to the manufacturer’s recommendations. RNA
quality and quantity was determined by Nanodrop (Nanodrop
Technologies, Wilmington, DE, USA) and Agilent’s 2100
Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA). Total
RNAs with high quality were subjected to NGS analysis
performed at Theragen Bio Institute (Suwon-city, Gyeonggi-do,
The Republic of Korea).
Table 1. Cont.
Chr Polycistronic miRNAs Positions in chr
X miR-374a, miR-545 55500596–55500517
X miR-374b, miR-421 55435984–55435897
X miR-502, miR-660, miR-500-2, miR-501, miR-362, miR-500 40077407–40073367
X miR-188, miR-532 40068847–40068549
X miR-222, miR-221 37091426–37090756
doi:10.1371/journal.pone.0093662.t001
Figure 6. The percentage distribution of the first nucleotide at the 59 end of all miRNAs of all lengths. Various nucleotides are detected
at the 59 end of miRNA sequences. In general, U is the predominant nucleotide at 59 end of all miRNAs of all lengths except for miRNAs of lengths 19
and 21.
doi:10.1371/journal.pone.0093662.g006
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The total RNAs were separated on 15% denaturation
polyacrylamide gels, and the band of small RNA fragments
between 18 and 32 nt in size were excised. Recovered RNAs from
the gels were ligated to a 59 adaptor and a 39 adaptor sequentially,
and reverse-transcribed to cDNA to obtain sufficient product for
Illumina short read sequencing technology (Hiseq 2000). The
cDNA products of the small RNA fragments were sequenced
directly using Illumina HiSeq 2000 sequencer (Illumina Inc, San
Diego, CA, USA) following the Illumina’s protocols.
Sequence analysis of small RNAs
The sequence tags from the NGS were subject to a data
cleaning process, which removes the low quality reads, 59 primer
contaminants, reads without 39 primer or insert tag, reads with
poly A, and reads shorter than 18 nt. Then, standard bioinfor-
matics analyses were carried out to annotate the resultant clean
tags into different categories. The small RNA tags were annotated
using the Rfam RNA family database (http://www.sanger.ac.uk/
software/Rfam) and the NCBI GenBank noncoding RNA
database (http://www.ncbi.nlm.nih.gov/). Sequences perfectly
matching the equine genome along their entire length were
subjected to subsequent analyses. Sequences matching known
equine small RNAs such as rRNA, scRNA, snoRNA, snRNA and
tRNA or degradation fragments of mRNAs were excluded in
further analyses.
Identification of conserved and novel miRNAs
The small RNAs cleaned with Genbank and Rfam were aligned
against the miRNA databases, miRBase15.0, to identify the
conserved miRNA sequences. Whenever there was miRNA
information of horse in miRBase 15.0, perfectly matched
sequences were considered as known miRNAs. The small RNAs
that cannot be annotated to any category were subjected to novel
miRNA prediction software, Mireap (http://sourceforge.net/
projects/mireap/), which is utilized to predict novel miRNA by
exploring the secondary structure, the Dicer cleavage site and the
minimum free energy of the unannotated small RNA tags that
could be mapped to the horse genome. Potential novel miRNA
candidates should meet the following 10 parameters according to
Mireap. (1) minimal miRNA sequence length of 18 nt and
maximal miRNA sequence length of 26 nt; (2) minimal miRNA
reference sequence length of 20 nt and maximal miRNA reference
sequence length of 24 nt; (3) minimal depth of Drosha/Dicer
cutting site, 3 nt; (4) maximal copy number of miRNAs on
reference, 20 nt; (5) maximal free energy allowed for a miRNA
precursor, 218 kcal/mol; (6) maximal space between miRNA and
miRNA*, 35 nt; (7) minimal base pairs of miRNA and miRNA*,
14 nt (8) maximal bulge of miRNA and miRNA*, 4 nt; (9)
maximal asymmetry of miRNA/miRNA* duplex, 5 nt; and (10)
flank sequence length of miRNA precursor, 10 nt. The sequencing
data of the conserved and novel miRNAs were deposited in the
National Center for Biotechnology Information Sequence Read
Archive (http://www.ncbi.nlm.nih.gov/Traces/sra/) under sub-
mission number SRA058805.
Characterization of equine miRNAs
To analyze chromosomal distribution, the known miRNAs
identified in the miRBase database were mapped to the genome
by an alignment program Short Oligonucleotide Analysis Package
software (SOAP, http://soap.genomics.org.cn). The miRNAs on
each chromosome were grouped into clusters based on their
locations in the equine genome. If two miRNAs were within 3 kb
Figure 7. The percentage distribution of base composition at each position of miRNAs. MiRNAs in all combined tissues.
doi:10.1371/journal.pone.0093662.g007
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of each other, they were considered as being in the same cluster
[34]. Using Illumina Hiseq 2000 sequencer, a more detailed
analysis was also performed to further characterize the base
composition of miRNA sequences. miRNA Sequences were
aligned to the miRNA precursor of horse (mature miRNA if
there is no precursor information in miRBase15.0) to predict the
base bias in the first position of identified miRNAs of certain
length and at each position of all the identified miRNAs.
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Table S2 Distribution of the genome-mapped sequence
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